Boothbay Fund Management, LLC Pacira Bio Sciences, Inc. Transaction History

Boothbay Fund Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$36.12 - $47.5 $182,803 - $240,397	5,061 Added 87.94%	10,816 $433,000
Q1 2023 May 15, 2023	BUY	$35.53 - $43.38 $204,475 - $249,651	5,755 New	5,755 $234,000
Q3 2020 Nov 16, 2020	SELL	$51.97 - $63.0 $369,506 - $447,930	-7,110 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$30.8 - $52.47 $218,988 - $373,061	7,110 New	7,110 $373,000

263

50.4M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $892M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.